JP Patent

JP7521897B2 — 医薬品有効成分の自己調節放出のための方法及び組成物

Assigned to アキュラ・ファーマシューティカルズ・インコーポレーテッド · Expires 2024-07-24 · 2y expired

What this patent protects

Patent listed against Keppra.

Drugs covered by this patent

Keppra (levetiracetam) · Generic (originally UCB Pharma)

Patent Metadata

Patent number: JP7521897B2
Jurisdiction: JP
Classification: —
Expires: 2024-07-24
Drug substance claim: No
Drug product claim: No
Assignee: アキュラ・ファーマシューティカルズ・インコーポレーテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.